children
present
acut
onset
barki
cough
stridor
chestwal
indraw
croup
care
histori
physic
examin
best
method
confi
rm
diagnosi
rule
potenti
seriou
altern
disord
bacteri
tracheiti
rare
caus
upperairway
obstruct
epinephrin
deliv
via
nebulis
eff
ectiv
temporari
relief
symptom
airway
obstruct
corticosteroid
mainstay
treatment
benefi
seen
children
level
sever
croup
includ
mild
case
croup
common
childhood
diseas
characteris
sudden
onset
distinct
barki
cough
usual
accompani
stridor
hoars
voic
respiratori
distress
result
upperairway
obstruct
although
children
croup
deem
mild
shortliv
ill
distress
disrupt
famili
undergo
well
known
perhap
upset
natur
croup
present
unusu
frighten
predominantli
aff
ect
young
children
symptom
usual
wors
earli
hour
morn
histor
advent
treatment
corticosteroid
racem
epinephrin
sever
croup
intub
tracheotomi
death
typic
outcom
treatment
evolv
barbar
method
includ
bleed
applic
leech
mist
kettl
pot
boil
water
mist
room
mist
tent
current
evidencebas
practic
corticosteroid
epinephrin
deliv
via
nebulis
mani
unansw
question
linger
croup
symptom
wors
night
predispos
children
sever
croup
other
mild
barki
cough
account
stubbornli
predict
biannual
peak
occurr
croup
caus
croup
evolv
new
viral
trigger
identifi
ed
bacteri
tracheiti
new
emerg
complic
croup
seminar
summaris
current
publish
work
epidemiolog
diagnosi
manag
import
childhood
diseas
propos
futur
research
pathway
explor
croup
one
frequent
caus
acut
respiratori
distress
young
children
diseas
mainli
aff
ect
age
month
year
old
peak
annual
incid
second
year
life
nearli
howev
croup
occur
babi
young
month
old
adolesc
although
rare
adult
also
develop
croup
symptom
boy
suscept
girl
disord
overal
malefemal
preponder
north
america
croup
season
peak
late
autumn
septemb
decemb
case
recognis
throughout
year
even
summer
oddnumb
year
number
children
admit
croup
peak
season
evennumb
year
close
correl
preval
parainfl
uenza
viru
infect
commun
north
america
symptom
onset
typic
abrupt
usual
happen
night
herald
appear
characterist
distinct
barki
cough
stridor
hoars
voic
respiratori
distress
seen
frequent
result
upperairway
obstruct
symptom
frequent
preced
nonspecifi
c
upperrespiratorytract
symptom
h
develop
barki
cough
diffi
culti
breath
croup
symptom
gener
shortliv
children
show
resolut
barki
cough
within
h
howev
children
continu
symptom
week
croup
symptom
nearli
alway
becom
wors
nighttim
hour
experi
fl
uctuat
sever
depend
whether
child
agit
calm
know
croup
symptom
tend
worsen
night
physiolog
plausibl
explan
might
lie
known
circadian
fl
uctuat
endogen
serum
cortisol
concentr
peak
h
reach
trough
h
h
asthma
anoth
frequent
respiratori
diseas
nighttim
symptom
gener
prevail
postul
mechan
includ
detriment
eff
ect
nocturn
airway
cool
gastrooesophag
refl
ux
increas
tissu
infl
ammat
addit
eff
ect
endogen
plasma
cortisol
epinephrin
cycl
perhap
similar
physiolog
factor
play
croup
symptom
croup
result
upperairway
obstruct
caus
acut
viral
infect
search
cochran
librari
medlin
term
croup
acut
laryngotracheobronch
acut
laryngotrach
spasmod
croup
date
languag
restrict
includ
randomis
control
trial
origin
studi
critic
review
metaanalys
treatment
croup
also
refer
commonli
referenc
import
older
public
addit
review
bibliographi
highli
relev
report
identifi
ed
origin
search
bibliograph
databas
typic
parainfl
uenza
type
virus
implic
disord
includ
infl
uenza
infl
uenza
b
adenoviru
respiratori
syncyti
viru
metapneumoviru
publish
work
strong
associ
describ
human
metapneumoviru
coronaviru
infect
croup
children
whether
new
pathogen
emerg
unknown
howev
like
possibl
increas
number
virus
seen
associ
croup
mere
refl
ection
improv
method
detect
work
ongo
develop
eff
ectiv
vaccin
parainfl
uenza
viru
laryng
diphtheria
wellknown
histor
caus
croup
occurr
rare
immunis
popul
howev
outbreak
diphther
croup
report
case
seri
russia
india
measl
remain
import
caus
croup
nonimmunis
children
treatment
vitamin
assess
report
eff
ectiv
prevent
secondari
infect
especi
croup
children
sever
measl
rariti
croup
associ
measl
diphtheria
immunis
children
suggest
substanti
progress
could
made
develop
world
continu
aggress
immunis
programm
pathogen
infect
recognis
pathogen
lead
generalis
airway
infl
ammat
oedema
upperairway
mucosa
includ
larynx
trachea
bronchi
epitheli
necrosi
shed
parainfl
uenza
viru
also
activ
chlorid
secret
inhibit
sodium
absorpt
across
tracheal
epithelium
contribut
airway
oedema
subglott
region
becom
narrow
result
barki
cough
turbul
airfl
ow
stridor
chestwal
indraw
narrow
lead
asynchron
chestwal
abdomin
movement
fatigu
eventu
hypoxia
hypercapnia
respiratori
failur
children
develop
sever
symptom
recurr
episod
croup
wherea
other
show
mild
symptom
even
asymptomat
face
infect
perhap
individu
anatomi
play
part
sinc
children
might
intrins
narrow
subglott
space
individu
immun
factor
could
import
rang
sever
infl
ammatori
respons
infect
peak
incid
croup
age
year
also
somewhat
unexplain
could
attribut
increas
exposur
viral
pathogen
combin
toddler
smaller
subglott
space
leav
greater
risk
airway
narrow
current
publish
work
topic
mention
question
although
major
concern
clinician
parent
potenti
sever
respiratori
distress
morbid
mortal
children
mild
shortliv
symptom
children
present
gener
emerg
depart
provinc
alberta
canada
classifi
ed
mild
croup
fewer
sever
croup
unpublish
data
even
though
children
fairli
mild
symptom
sudden
onset
croup
symptom
night
caus
mani
parent
bring
child
emerg
depart
consist
fi
nding
fewer
children
croup
admit
hospit
populationbas
studi
croup
admit
intub
mortal
seem
rare
extrapol
data
sever
sourc
estim
mortal
rate
case
child
present
classic
sign
symptom
croup
altern
diagnos
uncommon
panel
howev
clinician
must
remain
vigil
seriou
diseas
present
stridor
respiratori
distress
bacteri
tracheiti
seriou
lifethreaten
bacteri
infect
aris
acut
viral
respiratorytract
infect
child
usual
mildtomoder
ill
day
becom
acut
wors
febril
toxic
appear
ie
look
unwel
reduc
interact
environ
respond
favour
treatment
nebulis
epinephrin
bacteri
tracheiti
consid
treatment
includ
close
monitor
airway
broadspectrum
intraven
antibiot
intub
respiratori
support
might
need
earli
stage
treatment
thick
tracheal
secret
occlud
airway
frequent
isol
pathogen
staphylococcu
aureu
other
includ
group
streptococcu
moraxella
catarrhali
streptococcu
pneumonia
haemophilu
infl
u
enza
anaerob
bacteria
also
cultur
tracheal
secret
children
tracheiti
second
potenti
lifethreaten
altern
diagnosi
epiglott
diseas
seen
rare
owe
widespread
immunis
h
infl
uenza
b
sudden
onset
high
fever
drool
dysphagia
anxieti
prefer
sit
upright
socal
sniffi
ng
posit
ie
sit
forward
head
extend
open
airway
prompt
consider
epiglott
cough
characterist
bark
sound
croup
case
possibl
epiglott
bacteri
tracheiti
import
aspect
treatment
mainten
secur
airway
doctor
highli
skill
airway
manag
rare
caus
stridor
consid
children
present
atyp
croup
symptom
includ
foreignbodi
aspir
upper
airway
oesophagu
peritonsillar
retropharyng
abscess
angiooedema
laryng
diphtheria
case
foreignbodi
aspir
onset
usual
sudden
prodrom
fever
unless
secondari
infect
occur
hoars
bark
cough
usual
absent
dysphagia
could
present
stridor
note
variabl
children
stridor
secondari
presenc
foreign
bodi
usual
present
clear
histori
ingest
peritonsillar
retropharyng
abscess
could
present
dysphagia
drool
stridor
dyspnoea
tachypnoea
neck
stiff
ness
unilater
cervic
adenopathi
later
neck
radiograph
show
posterior
pharyng
oedema
retrofl
exe
cervic
vertebra
acut
angioneurot
oedema
allerg
reaction
present
age
rapid
onset
dysphagia
stridor
possibl
cutan
allerg
sign
urticari
rash
children
might
histori
allergi
previou
attack
laryng
diphtheria
arisen
histor
peopl
age
record
inadequ
immunis
seen
usual
prodrom
pharyng
symptom
note
onset
gradual
day
lowgrad
fever
present
hoars
bark
cough
occur
along
dysphagia
inspiratori
stridor
characterist
membran
pharyng
seen
physic
examin
croup
clinic
diagnosi
key
featur
includ
acut
onset
seallik
barki
cough
stridor
hoars
respiratori
distress
children
might
fever
occasion
reach
temperatur
high
howev
drool
appear
toxic
laboratori
test
need
confi
rm
diagnosi
child
present
typic
clinic
featur
croup
test
judg
necessari
defer
child
respiratori
distress
notabl
rapid
antigen
test
viral
cultur
aid
routin
acut
manag
child
croup
similarli
radiolog
studi
recommend
child
typic
histori
croup
respond
appropri
treatment
radiograph
indic
clinic
pictur
epiglott
bacteri
tracheiti
children
diagnosi
uncertain
howev
anteroposterior
later
softtissu
neck
radiograph
help
support
altern
diagnosi
radiograph
obtain
howev
epiglott
suggest
thicken
epiglotti
aryepiglott
fold
retropharyng
abscess
indic
bulg
soft
tissu
posterior
pharynx
bacteri
tracheiti
manifest
rag
tracheal
contour
membran
span
trachea
howev
radiograph
also
complet
normal
children
diagnos
radiograph
justifi
ed
atyp
clinic
pictur
child
must
close
monitor
imag
skill
personnel
appropri
airway
manag
equip
airway
obstruct
worsen
rapidli
cardiorespiratori
monitor
includ
continu
puls
oximetri
indic
children
sever
croup
necessari
mild
case
also
children
without
sever
croup
could
occasion
low
oxygen
satur
presum
result
intrapulmonari
involv
viral
infect
thu
ongo
assess
overal
clinic
statu
import
determin
diseas
sever
reli
clinic
assess
variou
propos
method
object
assess
respiratori
distress
children
croup
either
impract
insensit
chang
across
full
rang
diseas
sever
consequ
clinic
trial
treatment
eff
ectiv
outcom
measur
mainli
includ
clinic
score
healthcar
use
although
score
use
research
studi
none
shown
enhanc
routin
clinic
care
least
part
reliabl
use
wide
rang
clinician
featur
use
routin
clinic
assess
children
croup
outlin
fi
gure
gener
consensu
children
croup
made
comfort
possibl
clinician
take
special
care
assess
treatment
frighten
upset
agit
caus
substanti
worsen
symptom
sit
child
comfort
lap
parent
caregiv
usual
best
way
lessen
agit
although
could
fi
nd
publish
evid
oxygen
administ
children
show
sign
respiratori
distress
widespread
consensu
indic
oxygen
treatment
benefi
cial
circumst
oxygen
gener
administ
without
caus
child
agit
via
plastic
hose
open
held
within
centimetr
nose
mouth
refer
blowbi
oxygen
treatment
croup
humidifi
ed
air
eff
ectiv
despit
long
histori
use
humidifi
cation
air
neither
complet
benign
improv
respiratori
distress
systemat
review
fi
nding
three
randomis
control
trial
humidifi
ed
air
treatment
emerg
set
total
children
mildtomoder
croup
conclud
diff
erenc
croup
score
treatment
systemat
review
includ
later
randomis
control
trial
children
moderatetosever
croup
paediatr
emerg
depart
randomis
three
arm
tradit
standard
humidifi
ed
blowbi
oxygen
humidifi
ed
oxygen
humidifi
ed
oxygen
particl
size
gener
target
larynx
measur
humidifi
ed
blowbi
oxygen
show
techniqu
rais
humid
ambient
room
air
thu
eff
ectiv
serv
placebo
arm
fi
nding
show
diff
erenc
croup
score
treatment
epinephrin
dexamethason
admiss
hospit
addit
medic
care
three
group
apart
lack
note
benefi
sever
potenti
diffi
culti
administr
humidifi
ed
air
identifi
ed
hot
humidifi
ed
air
caus
scald
injuri
mist
tent
dispers
fungu
mould
environ
unless
properli
clean
importantli
mist
tent
cold
wet
separ
child
parent
usual
caus
agit
worsen
symptom
helium
inert
lowdens
ga
inher
pharmacolog
biolog
eff
ect
administr
heliumoxygen
mixtur
heliox
children
sever
respiratori
distress
reduc
degre
distress
sinc
lower
densiti
helium
ga
vs
nitrogen
decreas
airfl
ow
turbul
narrow
airway
heliox
compar
racem
epinephrin
prospect
randomis
control
trial
children
moderatetosever
croup
receiv
treatment
humidifi
ed
oxygen
intramuscular
dexa
methason
clinic
outcom
includ
clinic
croup
score
oxygen
satur
heart
respiratori
rate
heliox
racem
epinephrin
associ
similar
improv
croup
score
time
find
second
prospect
randomis
doubleblind
control
trial
children
mild
croup
present
emerg
depart
indic
trend
toward
greater
improv
clinic
croup
score
heliox
group
versu
oxygenenrich
air
group
although
score
diff
er
signifi
cantli
howev
sinc
heliox
yet
shown
er
greater
improv
standard
treatment
diffi
cult
use
unskil
hand
insuffi
cient
reason
recommend
gener
use
children
sever
croup
furthermor
practic
limit
heliox
use
includ
limit
fraction
concentr
inspir
oxygen
child
signifi
cant
hypoxia
next
section
review
use
two
convent
treatment
corticosteroid
epinephrin
stridor
chestwal
indraw
rest
without
agit
stridor
indraw
sternum
associ
agit
lethargi
reprint
refer
permiss
sever
categori
drug
antipyret
analges
antibiot
agonist
decongest
rational
review
latter
group
drug
although
treatment
recommend
sometim
use
children
croup
corticosteroid
long
histori
use
children
croup
evid
eff
ectiv
treatment
croup
clear
tabl
children
sever
croup
impend
respiratori
failur
treat
corticosteroid
fi
vefold
reduct
rate
intub
intub
remain
ventil
third
less
time
sevenfold
lower
risk
reintub
patient
treat
drug
moderatetosever
croup
patient
treat
corticosteroid
averag
reduct
length
stay
emerg
depart
hospit
reduct
absolut
proport
treat
nebulis
epinephrin
reduct
number
return
visit
admiss
treatment
compar
children
treat
corticosteroid
mild
croup
treat
drug
less
like
return
medic
care
ongo
symptom
lose
less
sleep
cours
ill
parent
report
less
stress
parent
children
treat
corticosteroid
treatment
drug
also
yield
small
clinic
import
societ
econom
benefi
ts
famili
healthcar
system
result
total
save
per
child
benefi
ts
treat
children
mild
croup
aris
irrespect
durat
child
symptom
sever
ill
date
advers
eff
ect
associ
use
corticosteroid
children
croup
howev
diffi
culti
aris
attempt
identifi
prove
rare
advers
eff
ect
aris
drug
treatment
thu
remain
vigil
possibl
import
best
rout
administr
corticosteroid
children
croup
investig
extens
outcom
result
griffi
n
oral
intramuscular
rout
either
equival
superior
inhal
addit
inhal
budesonid
oral
dexamethason
children
admit
croup
confer
addit
advantag
two
trial
oral
intramuscular
administr
dexamethason
compar
diff
erenc
record
resolut
croup
symptom
return
medic
care
admiss
hospit
treatment
corticosteroid
epinephrin
find
studi
compar
intramuscular
dexamethason
oral
betamethason
note
diff
erenc
reduct
croup
score
treatment
hospit
admiss
time
symptom
resolut
return
medic
care
studi
corticosteroid
administ
oral
mainli
incorpor
dexamethason
two
compar
studi
publish
oral
agent
treatment
croup
fi
rst
one
oral
dose
prednisolon
compar
dexamethason
fi
nding
show
superior
dexamethason
reduc
rate
return
medic
care
second
studi
oral
dexamethason
compar
oral
prednisolon
diff
erenc
note
reduct
croup
score
rate
return
medic
care
practic
consider
could
oral
dexamethason
associ
less
vomit
oral
prednison
substanti
advantag
practic
issu
also
consid
instanc
child
persist
vomit
inhal
intramuscular
rout
drug
deliveri
might
prefer
case
sever
respiratori
distress
oral
administr
could
diffi
cult
child
toler
intramuscular
dose
child
hypoxia
decreas
gut
local
tissu
perfus
impair
absorpt
via
oral
intramuscular
rout
respect
case
inhal
rout
consid
would
also
allow
administr
oxygen
racem
epinephrin
concurr
cost
treatment
rout
also
thought
respect
dose
corticosteroid
two
import
question
ask
first
one
dose
dexamethason
suffi
cient
sever
requir
second
appropri
size
dexamethason
dose
mgkg
mgkg
mgkg
fi
nd
randomis
trial
via
literatur
search
singl
multipl
dose
corticosteroid
compar
publish
randomis
trial
eff
ectiv
corticosteroid
roughli
split
term
use
either
one
dose
sever
theoret
sinc
children
croup
symptom
resolv
within
h
specul
durat
antiinfl
ammatori
eff
ect
dexamethason
day
necess
second
dose
would
seem
unlik
children
disord
convent
dose
dexamethason
deem
mgkg
altern
dose
mgkg
propos
confl
ict
evid
dose
size
provid
metaanalysi
fi
nding
four
randomis
trial
metaanalysi
six
studi
children
admit
hospit
higher
dose
hydrocortison
equival
use
higher
proport
children
respond
corticosteroid
treatment
compar
placebo
howev
sinc
design
includ
studi
diff
ere
possibl
bia
exist
hand
four
studi
diff
erent
dose
oral
dexamethason
compar
publish
rang
croup
sever
inpati
outpati
set
includ
tabl
none
trial
design
noninferior
studi
small
sampl
size
none
four
studi
show
signifi
cant
diff
erenc
primari
outcom
measur
corticosteroid
dose
size
fi
nding
four
randomis
control
trial
suggest
dose
mgkg
might
adequ
wherea
systemat
review
metaanalysi
six
studi
indic
higher
dose
could
provid
greater
benefi
children
sever
diseas
although
steroid
treatment
children
croup
gener
known
safe
potenti
concern
exist
respect
possibl
advers
event
first
children
treat
steroid
exposur
varicella
viru
increas
risk
develop
complic
varicella
dissemin
diseas
bacteri
superinfect
publish
casecontrol
studi
address
issu
yield
confl
ict
result
wherea
one
studi
increas
risk
complic
varicella
immunocompet
children
treat
steroid
note
anoth
fi
nding
seen
us
food
drug
administr
american
academi
pediatr
american
academi
allergi
immunolog
advis
caution
use
steroid
children
expos
varicella
viru
relat
issu
potenti
concern
corticosteroid
use
could
prolong
viral
shed
howev
unabl
fi
nd
evid
address
issu
steroid
treatment
potenti
complic
yet
proven
includ
bacteri
tracheiti
pneumonia
gastrointestin
bleed
bacteri
tracheiti
propos
relat
previous
unsuspect
immun
dysfunct
respect
pneumonia
retrospect
case
review
immunesuppress
stemcel
transplant
cipient
import
factor
associ
develop
parainfl
uenza
pneumonia
dose
corticosteroid
time
infect
acquisit
gastrointestin
bleed
would
seem
unlik
otherwis
healthi
children
could
concern
child
sever
diseas
requir
care
intensivecar
unit
endotrach
intub
repeat
high
dose
steroid
children
moderatetosever
croup
treatment
epinephrin
via
nebulis
long
histori
well
studi
tabl
use
histor
comparison
administr
epinephrin
children
sever
croup
report
reduc
number
need
intub
trach
ot
omi
substanti
amount
nebulis
racem
epinephrin
compar
placebo
improv
croup
score
within
min
initi
treatment
three
randomis
control
trial
fourth
placebocontrol
trial
clear
benefi
record
howev
trial
welldesign
wellreport
object
pathophysiolog
measur
sever
also
shown
substanti
improv
epinephrin
treatment
fi
prospect
cohort
studi
clinic
eff
ect
sustain
least
h
essenti
gone
within
h
administr
reassuringli
eff
ect
epinephrin
wear
patient
symptom
returnon
averageto
baselin
sever
seem
worsen
combin
data
fi
prospect
clinic
trial
outpati
treat
epinephrin
dexamethason
budesonid
observ
h
also
reassur
children
discharg
home
return
care
within
h
six
admit
hospit
children
advers
outcom
prospect
deriv
data
along
fi
nding
two
retrospect
cohort
studi
provid
favour
support
children
safe
discharg
home
treatment
epinephrin
long
symptom
recur
within
h
treatment
administr
one
dose
time
nebulis
epinephrin
children
associ
advers
eff
ect
clinic
signifi
cant
increas
either
heart
rate
blood
pressur
conclus
critic
review
seven
clinic
trial
children
treat
nebulis
epinephrin
patient
receiv
dose
ml
greater
either
croup
acut
bronchiol
note
epinephrin
safe
treatment
identifi
ed
mild
sideeff
ect
includ
frequent
tachycardia
pallor
one
case
report
publish
previous
healthi
child
sever
croup
develop
ventricular
tachycardia
myocardi
infarct
treatment
three
dose
epinephrin
via
nebulis
within
h
racem
epinephrin
tradit
use
treat
children
croup
howev
epinephrin
eff
ectiv
safe
racem
form
shown
fi
nding
randomis
trial
children
age
month
year
moderatetosever
croup
studi
dose
use
children
irrespect
size
ml
racem
epinephrin
ml
epinephrin
data
deriv
use
aerosolis
medic
lowerairway
diseas
support
approach
eff
ectiv
dose
drug
deliv
airway
regul
everi
individu
tidal
volum
analges
antipyret
antibiot
antituss
decongest
shortact
agonist
retriev
control
trial
eff
ectiv
drug
treatment
croup
literatur
search
use
analges
antipyret
reason
benefi
reduct
fever
discomfort
children
croup
type
croup
viral
caus
although
socal
superinfect
bacteri
tracheiti
pneumonia
describ
rare
frequenc
per
case
croup
make
use
prophylact
antibiot
unreason
physiolog
ration
basi
exist
use
antituss
decongest
administ
children
croup
similarli
view
pathophysiolog
croup
upperairway
diseas
clear
reason
use
shortact
agonist
treatment
diseas
indic
admiss
discharg
medic
care
although
children
croup
manag
safe
outpati
littl
publish
evid
avail
guid
clinician
individu
admit
hospit
data
retrospect
cohort
children
admit
royal
children
hospit
melbourn
persist
stridor
rest
routin
treatment
corticosteroid
show
persist
sternal
indraw
present
emerg
depart
risk
endotrachael
intub
wherea
without
sternal
chestwal
indraw
recov
rapidli
without
specifi
c
treatment
studi
compar
dexamethason
placebo
record
reduct
admiss
dexamethasonetr
group
fi
rst
note
h
later
increas
diff
erenc
shown
h
treatment
rate
admiss
dexamethasonetr
group
half
given
placebo
fi
nding
suggest
observ
emerg
depar
least
h
ideal
h
treatment
corticosteroid
would
reduc
admiss
rate
presum
benefi
cial
eff
ect
corticosteroid
becom
evid
time
publish
report
look
length
stay
emerg
depart
admiss
substanti
reduct
record
admiss
implement
clinic
pathway
mandat
h
observ
emerg
depart
corticosteroid
treatment
child
croup
admit
hospit
base
evid
combin
expert
opinion
alberta
medic
associ
clinic
pathway
committe
develop
implement
manag
algorithm
outlin
fi
gure
year
controversi
corticosteroid
fi
rmli
establish
treatment
choic
children
croup
although
compar
fewer
report
publish
epinephrin
suffi
cient
data
exist
support
drug
role
shortterm
symptom
relief
corticosteroid
take
eff
ect
convers
centuri
use
defi
nitiv
evid
avail
show
ineff
ectiv
mist
apart
heliox
new
therapeut
intervent
horizon
nonetheless
corticosteroid
epinephrin
greatli
reduc
healthcar
use
enhanc
outcom
children
croup
although
eff
ectiv
treatment
croup
wellestablish
sever
mysteri
remain
unexplain
respect
caus
pathophysiolog
diseas
explor
question
could
ultim
yield
novel
even
eff
ectiv
treatment
vaccin
epinephrin
dose
primari
outcom
result
taussig
moder
sever
ml
weight
epinephrin
clinic
croup
score
min
treatment
improv
kristjansson
